AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration

Published:2018-02 Issue:2 Volume:26 Page:542-549
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Liu Yuanyuan,Fortmann Seth D.,Shen Jikui,Wielechowski Erik,Tretiakova Anna,Yoo Stephen,Kozarsky Karen,Wang Jiangxia,Wilson James M.,Campochiaro Peter A.

Funder

REGENXBIO

Wilmer Biostatistics

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference30 articles.

1. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N. Engl. J. Med.,2006

2. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N. Engl. J. Med.,2006

3. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration;Singer;Ophthalmology,2012

4. Ranibizumab and bevacizumab for neovascular age-related macular degeneration;Martin;N. Engl. J. Med.,2011

5. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascula age-related macular degeneration. The comparison of age-related macular degeneration treatment trials;Maguire;Ophthalmology,2016

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical development of a dual targeting bicistronic gene therapy approach for the treatment of wet age-related macular degeneration;2024-07-22

2. The Role of Reactive Oxygen Species in Age-Related Macular Degeneration: A Comprehensive Review of Antioxidant Therapies;Biomedicines;2024-07-16

3. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks;Ageing Research Reviews;2024-07

4. An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species;Nature Communications;2024-05-06

5. Perspectives on the currently available pharmacotherapy for wet macular degeneration;Expert Opinion on Pharmacotherapy;2024-04-12